2DPA-1 市場規模、佔有率和成長分析（按應用、最終用途和地區）- 產業預測 2025-2032

2023 年 2DPA-1 市場規模價值為 6,654.4 億美元，預計將從 2024 年的 6,907.3 億美元成長到 2032 年的 9,308.6 億美元，預測期內（2025-2032 年）的複合年成長率為 3.8%。

2DPA-1 的全球市場正在不斷成長，這得益於該化合物在製藥、農業化學品、染料製造、個人護理等各個領域的廣泛應用。 2DPA-1（2-二苯乙醯-1,3-茚滿二酮）以其獨特的性能而聞名，是許多配方中的關鍵化學中間體，並因其有益的特性而受到讚譽，例如在護膚產品中的抗衰老和抗氧化特性。各行各業日益成長的需求凸顯了尋求利用創新解決方案的市場相關人員的巨大成長潛力。此外，預計美國2DPA-1 市場在未來一年將保持持續的複合年成長率，凸顯了這個充滿活力的領域的投資和市場發展機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

2DPA-1 市場規模：依應用與複合年成長率（2025-2032）

• 市場概況
• 藥品
• 農業化學品
• 化妝品
• 其他

2DPA-1 市場規模：依最終用途及複合年成長率（2025-2032）

• 市場概況
• 衛生保健
• 纖維和染料
• 其他

2DPA-1 市場規模：依地區及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Siemens AG（Germany）
• GE Healthcare（United States）
• Philips Healthcare（Netherlands）
• Canon Medical Systems Corporation（Japan）
• Hitachi, Ltd.（Japan）
• Toshiba Medical Systems Corporation（Japan）
• Koninklijke Philips NV（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• Carestream Health, Inc.（United States）
• Esaote SpA（Italy）
• Samsung Medison Co., Ltd.（South Korea）
• Hologic, Inc.（United States）
• Mindray Medical International Limited（China）
• Agfa-Gevaert NV（Belgium）
• Shimadzu Corporation（Japan）
• CurveBeam LLC（United States）
• Planmed Oy（Finland）
• Medtronic plc（Ireland）
• Varian Medical Systems, Inc.（United States）
• Epiroc AB（Sweden）

結論和建議

2DPA-1 Market size was valued at USD 665.44 billion in 2023 and is poised to grow from USD 690.73 billion in 2024 to USD 930.86 billion by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).

The global 2DPA-1 market is on the rise, driven by the compound's versatile applications in various sectors, including pharmaceuticals, agrochemicals, dye production, and personal care. Known for its unique properties, 2DPA-1 (2-diphenylacetyl-1,3-indandione) serves as a critical chemical intermediate in many formulations and is praised for its beneficial attributes like anti-aging and antioxidant effects in skincare products. This escalating demand across diverse industries underscores significant growth potential for market players looking to leverage innovative solutions. Furthermore, the US 2DPA-1 market is anticipated to maintain a sustainable CAGR in the coming forecast year, highlighting an opportune moment for investment and development in this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the 2DPA-1 market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

2DPA-1 Market Segments Analysis

Global 2DPA-1 Market is segmented by Application, End Use and region. Based on Application, the market is segmented into Pharmaceuticals, Agrochemicals, Cosmetics and Others. Based on End Use, the market is segmented into Healthcare, Textile & Dye and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the 2DPA-1 Market

The pharmaceutical sector is perpetually on the lookout for new and groundbreaking drug candidates to tackle diverse health issues. The distinctive therapeutic attributes of 2DPA-1-encompassing anti-inflammatory, anti-cancer, and antiviral properties-are propelling its utilization in drug discovery and development. This increasing interest and reliance on 2DPA-1 are contributing to a notable cumulative annual growth rate (CAGR) for the global market of 2DPA-1 over the projected timeframe. As the demand for effective treatments escalates, 2DPA-1 stands out as a promising candidate, further stimulating its integration into various therapeutic applications and solidifying its position within the pharmaceutical landscape.

Restraints in the 2DPA-1 Market

The emergence of new entrants in both regional and global markets may enhance competitiveness, potentially jeopardizing the positions of established players. As these newcomers introduce innovative products and diversify their offerings, existing businesses must adapt and refine their strategies to maintain market share. A robust and improved product portfolio from competitors could heighten the stakes, prompting a more aggressive approach to marketing and innovation among current players. This dynamic landscape necessitates that established firms continually assess their value propositions and respond effectively to the challenges posed by fresh market participants, ensuring their sustainability and growth in an increasingly competitive environment.

Market Trends of the 2DPA-1 Market

The 2DPA-1 market is currently facing a trend characterized by its intricate and costly production processes, which impede its broader adoption across industries. As manufacturers grapple with high production costs, the economic viability of 2DPA-1 becomes a significant concern, potentially limiting its accessibility and affordability. This financial barrier could hinder market expansion, resulting in a relatively modest compound annual growth rate (CAGR) throughout the forecast period. Despite its potential applications, the complexity of 2DPA-1 manufacturing may deter widespread usage, making it essential for industry players to innovate and streamline production techniques to boost market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global 2DPA-1 Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pharmaceuticals
• Agrochemicals
• Cosmetics
• Others

Global 2DPA-1 Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Healthcare
• Textile & Dye
• Others

Global 2DPA-1 Market Size & CAGR (2025-2032)

• North America (Application, End Use)
  • US
  • Canada
• Europe (Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Siemens AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toshiba Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esaote SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agfa-Gevaert NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CurveBeam LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epiroc AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations